Caregiver-Patient Intervention for Type 2 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on education and support rather than medication changes.
What data supports the effectiveness of the Joint Home-DM-BAT treatment for Type 2 Diabetes?
Research shows that family support and psychological interventions can help improve blood sugar control in people with type 2 diabetes. Additionally, programs that enhance self-management and involve patient engagement have been found to improve diabetes outcomes, suggesting that involving caregivers in diabetes management could be beneficial.12345
Is the Caregiver-Patient Intervention for Type 2 Diabetes safe for humans?
The available research does not provide specific safety data for the Caregiver-Patient Intervention for Type 2 Diabetes or its related names. However, the studies focus on improving diabetes management and self-care, which suggests that the interventions are generally aimed at supporting health rather than posing safety risks.45678
How is the Joint Home-DM-BAT treatment for Type 2 Diabetes different from other treatments?
What is the purpose of this trial?
This study will test the preliminary efficacy of a joint patient/informal caregiver telephone-delivered intervention that includes diabetes education; problem solving around social needs; and behavioral activation for older African Americans with poorly controlled type 2 diabetes by randomizing 100 patient/caregiver dyads to the Joint Home intervention (n=50) and usual care (n=50) arms.The aims of the study are:Aim 1: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) on patient clinical outcomes (hemoglobin A1c, blood pressure, and LDL-Cholesterol).Aim 2: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) Joint Home DM-BAT on patient quality of life.Aim 3: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) on caregiver quality of life and caregiver burden.
Eligibility Criteria
This trial is for older African Americans (50+) with poorly controlled type 2 diabetes (HbA1c ≥8%). Participants must self-identify as Black/African American, speak English, and have a caregiver willing to join the study. Caregivers should be ready to support the patient for six months and attend four one-hour sessions.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Joint Home-DM-BAT intervention with 8 weekly sessions and 3 monthly booster sessions via telephone
Follow-up
Participants are monitored for changes in clinical outcomes such as hemoglobin A1c, blood pressure, and LDL-Cholesterol
Treatment Details
Interventions
- Joint Home-DM-BAT Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor